Research graph
References from Reprogramming macrophage polarization via CD44-targeted and ROS-responsive apabetalone-loaded micelles for rheumatoid arthritis treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Apabetalone in chronic kidney disease
2021 · External reference
Reimagining drug nanocarriers: clinical realities and smarter strategies for targeted drug delivery
10.1039/d5mh00927h · 2025 · External reference
BET epigenetic reader proteins in cardiovascular transcriptional programs
10.1161/circresaha.120.315929 · 2020 · External reference
Visual and real-time detection of the critical micelle concentration of nonionic surfactants using a supramolecular aggregate probe responsive to stable micelles
10.1016/j.talanta.2024.127353 · 2025 · External reference
The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis
10.3389/fimmu.2022.867260 · 2022 · External reference
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases
10.1038/s41584-025-01279-w · 2025 · External reference
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
10.1038/nrrheum.2016.69 · 2016 · External reference
Mechanism underlying the action of Duanteng-Yimu Tang in regulating Treg/Th17 imbalance and anti-rheumatoid arthritis
2023 · External reference
Quantifying tight junction disruption caused by biomimetic pH-sensitive hydrogel drug carriers
10.1016/s1773-2247(08)50006-2 · 2008 · External reference
Advancing engineering design strategies for targeted cancer nanomedicine
10.1038/s41568-025-00847-2 · 2025 · External reference
Advancing design strategies in smart stimulus-responsive liposomes for drug release and nanomedicine
10.1002/bmm2.70045 · 2026 · External reference
Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier
10.1016/j.jconrel.2015.03.018 · 2015 · External reference
Megalin-targeting and ROS-responsive elamipretide-conjugated polymeric prodrug for treatment of acute kidney injury
10.1016/j.biopha.2024.116804 · 2024 · External reference
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
10.1016/j.atherosclerosis.2014.06.008 · 2014 · External reference
Hydrogels for ameliorating osteoarthritis: mechanical modulation, anti-inflammation, and regeneration
10.1002/bmm2.12078 · 2024 · External reference
Nanomaterial-based encapsulation of biochemicals for targeted sepsis therapy
2025 · External reference
A simple yet effective H2S-activated fluorogenic probe for precise imaging of hepatitis and arthritis in situ
10.1002/bmm2.12086 · 2025 · External reference
Rheumatology: what you may have missed in 2025
10.7326/annals-26-00984 · 2026 · External reference
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
10.1186/s12933-020-01199-x · 2021 · External reference
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis
10.1136/rmdopen-2025-006615 · 2026 · External reference
Advanced nanotherapies for precision treatment of inflammatory lung diseases
2025 · External reference
A biomimetic, triggered-release micelle formulation of methotrexate and celastrol controls collagen-induced arthritis in mice
2024 · External reference
Production of a magnetic nanocomposite for biological and hyperthermia applications based on chitosan-silk fibroin hydrogel incorporated with carbon nitride
10.1016/j.ijbiomac.2024.135052 · 2024 · External reference
Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis
10.4049/jimmunol.177.3.1932 · 2006 · External reference
Innovative transdermal drug delivery systems: benefits, challenges, and emerging application
10.1002/bmm2.70001 · 2025 · External reference
Comparative effects of commonly used intraocular dyes on the viability of human retina Müller cells
10.1016/j.biopha.2020.110790 · 2020 · External reference
Risk factors and clinical outcomes associated with sarcopenia in rheumatoid arthritis: a systematic review and meta-analysis
10.1097/rhu.0000000000001980 · 2024 · External reference
Recent advances in nanomedicines for the treatment of rheumatoid arthritis
10.1039/c7bm00254h · 2017 · External reference
Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis
10.1016/j.jconrel.2016.03.035 · 2016 · External reference
Combined ROS sensitive folate receptor targeted micellar formulations of curcumin effective against rheumatoid arthritis in rat model
10.2147/ijn.s458957 · 2024 · External reference
Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin
10.1083/jcb.200601113 · 2006 · External reference
Nanocarrier-based systems for targeted delivery: current challenges and future directions
2025 · External reference
Nanotherapeutics relieve rheumatoid arthritis
10.1016/j.jconrel.2017.02.032 · 2017 · External reference
Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy
10.1016/j.jconrel.2012.04.012 · 2012 · External reference
Paeoniflorin inhibits Rho kinase activation in joint synovial tissues of rats with collagen-induced rheumatoid arthritis
10.1016/j.biopha.2018.06.130 · 2018 · External reference
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
2022 · External reference
Hydrogels for ameliorating osteoarthritis: mechanical modulation, anti-inflammation, and regeneration
10.1002/bmm2.12078 · ExternalCitation · doi-reference
A simple yet effective H2S-activated fluorogenic probe for precise imaging of hepatitis and arthritis in situ
10.1002/bmm2.12086 · ExternalCitation · doi-reference
Innovative transdermal drug delivery systems: benefits, challenges, and emerging application
10.1002/bmm2.70001 · ExternalCitation · doi-reference
Advancing design strategies in smart stimulus-responsive liposomes for drug release and nanomedicine
10.1002/bmm2.70045 · ExternalCitation · doi-reference
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
10.1016/j.atherosclerosis.2014.06.008 · ExternalCitation · doi-reference
Paeoniflorin inhibits Rho kinase activation in joint synovial tissues of rats with collagen-induced rheumatoid arthritis
10.1016/j.biopha.2018.06.130 · ExternalCitation · doi-reference
Comparative effects of commonly used intraocular dyes on the viability of human retina Müller cells
10.1016/j.biopha.2020.110790 · ExternalCitation · doi-reference
Megalin-targeting and ROS-responsive elamipretide-conjugated polymeric prodrug for treatment of acute kidney injury
10.1016/j.biopha.2024.116804 · ExternalCitation · doi-reference
Production of a magnetic nanocomposite for biological and hyperthermia applications based on chitosan-silk fibroin hydrogel incorporated with carbon nitride
10.1016/j.ijbiomac.2024.135052 · ExternalCitation · doi-reference
Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy
10.1016/j.jconrel.2012.04.012 · ExternalCitation · doi-reference
Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier
10.1016/j.jconrel.2015.03.018 · ExternalCitation · doi-reference
Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis
10.1016/j.jconrel.2016.03.035 · ExternalCitation · doi-reference
Nanotherapeutics relieve rheumatoid arthritis
10.1016/j.jconrel.2017.02.032 · ExternalCitation · doi-reference
Visual and real-time detection of the critical micelle concentration of nonionic surfactants using a supramolecular aggregate probe responsive to stable micelles
10.1016/j.talanta.2024.127353 · ExternalCitation · doi-reference
Quantifying tight junction disruption caused by biomimetic pH-sensitive hydrogel drug carriers
10.1016/s1773-2247(08)50006-2 · ExternalCitation · doi-reference
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
10.1038/nrrheum.2016.69 · ExternalCitation · doi-reference
Advancing engineering design strategies for targeted cancer nanomedicine
10.1038/s41568-025-00847-2 · ExternalCitation · doi-reference
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases
10.1038/s41584-025-01279-w · ExternalCitation · doi-reference
Recent advances in nanomedicines for the treatment of rheumatoid arthritis
10.1039/c7bm00254h · ExternalCitation · doi-reference
Reimagining drug nanocarriers: clinical realities and smarter strategies for targeted drug delivery
10.1039/d5mh00927h · ExternalCitation · doi-reference
Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin
10.1083/jcb.200601113 · ExternalCitation · doi-reference
Risk factors and clinical outcomes associated with sarcopenia in rheumatoid arthritis: a systematic review and meta-analysis
10.1097/rhu.0000000000001980 · ExternalCitation · doi-reference
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis
10.1136/rmdopen-2025-006615 · ExternalCitation · doi-reference
BET epigenetic reader proteins in cardiovascular transcriptional programs
10.1161/circresaha.120.315929 · ExternalCitation · doi-reference
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
10.1186/s12933-020-01199-x · ExternalCitation · doi-reference
Combined ROS sensitive folate receptor targeted micellar formulations of curcumin effective against rheumatoid arthritis in rat model
10.2147/ijn.s458957 · ExternalCitation · doi-reference
The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis
10.3389/fimmu.2022.867260 · ExternalCitation · doi-reference
Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis
10.4049/jimmunol.177.3.1932 · ExternalCitation · doi-reference
Rheumatology: what you may have missed in 2025
10.7326/annals-26-00984 · ExternalCitation · doi-reference
